Using Human iPSC-Derived Neurons to Model TAU Aggregation

• An Verheyen ,

  * E-mail: AVerhey1@its.jnj.com

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Annick Diels,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Joyce Dijkmans,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Tutu Oyelami,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Giulia Meneghello,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Liesbeth Mertens,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Sofie Versweyveld,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Marianne Borgers,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Arjan Buist,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Pieter Peeters,

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯
• Miroslav Cik

  Affiliation Janssen Research & Development, a division of Janssen Pharmaceutica N.V, Beerse, Belgium

  ⨯